Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
111C-PBR28----[2] 6, 13
211C]PBR28----[1] 6
318F-PBR06----[1] 17
418F-PM-PBB3----[1] 13
54-PBA----[1] 231
6[18F] PBR06----[2] 6, 13
7[18F]PBR06----[1] 2
8[C-11]PBR28----[1] 13
9[F-18]PBR06----[1] 13
10ADA PBSC----[1] 65
11ETIMS (EDC-fixed autologous PBMCs coupled with 7 immunodominant myelin peptides in MS patients)[1] Myelin basic protein---[1] 13
12Gene transduced PBL and/or gene transduced HSC----[1] 65
13PB----[2] 67, 225
14PB006----[1] 13
15PB1046----[1] 86
16PB1046 Injection----[1] 113
17PB1046 Subcutaneous Injection----[1] 86
18PB1046, VIP-ELP1-120, Vasomera----[1] 86
19PBA----[1] 231
20PBF-509----[1] 6
21PBF-677----[1] 97
22PBF-999----[1] 8
23PBF-999 / 160 mg----[1] 8
24PBF-999 / 320 mg----[1] 8
25PBFT02----[1] 127
26PBGM01----[1] 19
27PBI4050----[2] 85, 299
28PBKR03----[1] 19
29PBMC autotransplantation----[1] 2
30PBT2----[1] 8
31Pemziviptadil (PB1046) Injection----[1] 86
32RAAV2/5-PBGD vector dosage 1----[1] 254
33RAAV2/5-PBGD vector dosage 2----[1] 254
34RAAV2/5-PBGD vector dosage 3----[1] 254
35RAAV2/5-PBGD vector dosage 4----[1] 254
36Vasomera (PB1046) Injection----[1] 86